E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant

ST Ishizaka, LD Hawkins - Expert review of vaccines, 2007 - Taylor & Francis
Safe and cost-effective adjuvants are a critical component to enhance the efficacy of subunit
vaccines. Studies have demonstrated that modified natural lipid As derived from …

E5531, a pure endotoxin antagonist of high potency

…, M Perez, Y Wang, GR Dubuc, WE Gavin, LD Hawkins… - Science, 1995 - science.org
Shock due to Gram-negative bacterial sepsis is a consequence of acute inflammatory
response to lipopolysaccharide (LPS) or endotoxin released from bacteria. LPS is a major …

Inhibition of endotoxin response by synthetic TLR4 antagonists

LD Hawkins, WJ Christ… - Current topics in medicinal …, 2004 - ingentaconnect.com
Endotoxin, from the outer membrane of Gram-negative bacteria, has been implicated as the
etiological agent of a variety of pathologies ranging from relatively mild (fever) to lethal (…

Total synthesis of palytoxin carboxylic acid and palytoxin amide

…, H Fujioka, WH Ham, LD Hawkins… - Journal of the …, 1989 - ACS Publications
The total synthesis of palytoxin carboxylic acid and palytoxin amide was achieved from the
fully protected palytoxin carboxylic acid. The fully protected palytoxin carboxylic acid 1 …

Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides …

…, TL Gioannini, JP Weiss, JC Chow, LD Hawkins… - MBio, 2012 - Am Soc Microbiol
Respiratory syncytial virus (RSV) is a leading cause of infant mortality worldwide. Toll-like
receptor 4 (TLR4), a signaling receptor for structurally diverse microbe-associated molecular …

Total synthesis of a fully protected palytoxin carboxylic acid

…, H Fujioka, WH Ham, LD Hawkins… - Journal of the …, 1989 - ACS Publications
The total synthesis of a fully protected palytoxin carboxylic acid was achieved from eight
building blocks 1, 2, 4, 6, 8, 9, 11, and 13. The C. 22-C. 23 and C. 37-C. 38 bonds were formed …

A series of (2S)-2-O-protected-2-hydroxypropanals (L-lactaldehydes) suitable for use as optically active intermediates

SK Massad, LD Hawkins, DC Baker - The Journal of Organic …, 1983 - ACS Publications
The synthesis and properties of a series of (2S)-2-0-protected-2-hydroxypropanals, where
theprotecting groups are tert-butyldimethylsilyl (3a), tert-butyldiphenylsilyl (3b), and (…

MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020)

…, M Tortoli, J Kazzaz, M Singh, LD Hawkins… - Pharmaceutical …, 2009 - Springer
Purpose The effectiveness of vaccines depends on the age and immunocompetence of the
vaccinee. Conventional non-adjuvanted influenza vaccines are suboptimal in the elderly and …

Total synthesis of the proposed structure of Rhodobacter sphaeroides lipid A resulting in the synthesis of new potent lipopolysaccharide antagonists

…, MA Mullarkey, M Perez, LD Hawkins… - Journal of the …, 1994 - ACS Publications
Hawkins, Todd A. Blythe, Gloria R. Dubuc,and Andrea L. …

[HTML][HTML] A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway

E Lien, JC Chow, LD Hawkins, PD McGuinness… - Journal of Biological …, 2001 - ASBMB
ER-112022 is a novel acyclic synthetic lipid A analog that contains six symmetrically organized
fatty acids on a noncarbohydrate backbone. Chinese hamster ovary (CHO)-K1 fibroblasts …